To assess the effect of Wnt5a on breast cancer cell migration, we treated MDA-MB-231 cells with different doses of recombinant Wnt5a (rWnt5a), and measured the migration rate by wound healing assay. This evidence concerns the gene WNT5A and breast carcinoma.